217 related articles for article (PubMed ID: 18983664)
1. Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
Neskey DM; Ambesi A; Pumiglia KM; McKeown-Longo PJ
J Exp Clin Cancer Res; 2008 Nov; 27(1):61. PubMed ID: 18983664
[TBL] [Abstract][Full Text] [Related]
2. Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.
Ambesi A; McKeown-Longo PJ
Mol Cancer Res; 2009 Feb; 7(2):255-65. PubMed ID: 19208746
[TBL] [Abstract][Full Text] [Related]
3. Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G(1) arrest in human microvessel endothelial cells.
Ambesi A; Klein RM; Pumiglia KM; McKeown-Longo PJ
Cancer Res; 2005 Jan; 65(1):148-56. PubMed ID: 15665290
[TBL] [Abstract][Full Text] [Related]
4. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
5. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T
Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
7. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
8. Effect of human recombinant Endostatin protein on human angiogenesis.
Jung SP; Siegrist B; Hornick CA; Wang YZ; Wade MR; Anthony CT; Woltering EA
Angiogenesis; 2002; 5(1-2):111-8. PubMed ID: 12549868
[TBL] [Abstract][Full Text] [Related]
9. Endostatin induces proliferation of oral carcinoma cells but its effect on invasion is modified by the tumor microenvironment.
Alahuhta I; Aikio M; Väyrynen O; Nurmenniemi S; Suojanen J; Teppo S; Pihlajaniemi T; Heljasvaara R; Salo T; Nyberg P
Exp Cell Res; 2015 Aug; 336(1):130-40. PubMed ID: 26112215
[TBL] [Abstract][Full Text] [Related]
10. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.
Sudhakar A; Sugimoto H; Yang C; Lively J; Zeisberg M; Kalluri R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4766-71. PubMed ID: 12682293
[TBL] [Abstract][Full Text] [Related]
11. Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice.
Li Q; Olsen BR
Am J Pathol; 2004 Aug; 165(2):415-24. PubMed ID: 15277216
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.
Delaney CE; Weagant BT; Addison CL
Exp Cell Res; 2006 Aug; 312(13):2476-89. PubMed ID: 16725139
[TBL] [Abstract][Full Text] [Related]
13. Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies.
Tee D; DiStefano J
J Cancer Res Clin Oncol; 2004 Jan; 130(1):15-24. PubMed ID: 14586644
[TBL] [Abstract][Full Text] [Related]
14. Endostatin signaling and regulation of endothelial cell-matrix interactions.
Wickström SA; Alitalo K; Keski-Oja J
Adv Cancer Res; 2005; 94():197-229. PubMed ID: 16096002
[TBL] [Abstract][Full Text] [Related]
15. Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model.
Tanabe K; Maeshima Y; Ichinose K; Kitayama H; Takazawa Y; Hirokoshi K; Kinomura M; Sugiyama H; Makino H
Kidney Int; 2007 Feb; 71(3):227-38. PubMed ID: 17191085
[TBL] [Abstract][Full Text] [Related]
16. Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.
Pufe T; Petersen WJ; Miosge N; Goldring MB; Mentlein R; Varoga DJ; Tillmann BN
Matrix Biol; 2004 Aug; 23(5):267-76. PubMed ID: 15464359
[TBL] [Abstract][Full Text] [Related]
17. Endostatin suppresses colorectal tumor-induced lymphangiogenesis by inhibiting expression of fibronectin extra domain A and integrin α9.
Ou J; Li J; Pan F; Xie G; Zhou Q; Huang H; Liang H
J Cell Biochem; 2011 Aug; 112(8):2106-14. PubMed ID: 21465533
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
[TBL] [Abstract][Full Text] [Related]
19. The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent.
Addison CL; Nör JE; Zhao H; Linn SA; Polverini PJ; Delaney CE
BMC Cell Biol; 2005 Oct; 6():38. PubMed ID: 16262896
[TBL] [Abstract][Full Text] [Related]
20. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]